Symmetry Medical, Inc. (SMA) Tops Q1 EPS by 2c; Reaffirms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailGet Alerts SMA Hot Sheet
Join SI Premium – FREE
Symmetry Medical, Inc. (NYSE: SMA) reported Q1 EPS of $0.09, $0.02 better than the analyst estimate of $0.07. Revenue for the quarter came in at $100.7 million versus the consensus estimate of $98.77 million.
Symmetry Medical, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.
Symmetry Medical, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Norwegian Cruise Line (NCLH) Tops Q3 EPS by 19c; offers guidance
- Brunswick (BC) Tops Q3 EPS by 22c, Misses on Revenue; Offers Guidance
- Trane Technologies (TT) Tops Q3 EPS by 13c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
